UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Stereoselective synthesis of C-6 hydroxy tricyclic sulfone as a γ-secretase inhibitor

Tetrahedron letters, 2011-06, Vol.52 (26), p.3382-3385

2011

Volltextzugriff (PDF)

Synthesis and SAR study of tricyclic sulfones as γ-secretase inhibitors: C-6 and C-8 positions

Bioorganic & medicinal chemistry letters, 2011-06, Vol.21 (11), p.3447-3451

2011

Volltextzugriff (PDF)

SAR studies of C2 ethers of 2H-pyrano[2,3-d]pyrimidine-2,4,7(1H,3H)-triones as nicotinic acid receptor (NAR) agonist

Bioorganic & medicinal chemistry letters, 2012-01, Vol.22 (2), p.854-858

2012

Volltextzugriff (PDF)

Chemoselective Peptide Modification via Photocatalytic Tryptophan β‑Position Conjugation

Journal of the American Chemical Society, 2018-06, Vol.140 (22), p.6797-6800

2018

Volltextzugriff (PDF)

Modification of the clozapine structure by parallel synthesis

Bioorganic & medicinal chemistry letters, 2006-09, Vol.16 (17), p.4548-4553

2006

Volltextzugriff (PDF)

Discovery of SCH 900271, a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia

ACS medicinal chemistry letters, 2012-01, Vol.3 (1), p.63-68

2012

Volltextzugriff (PDF)

SAR of tricyclic sulfones as γ-secretase inhibitors

Science China. Chemistry, 2011-11, Vol.54 (11), p.1688-1701

2011

Volltextzugriff (PDF)

Discovery of melanin-concentrating hormone receptor R1 antagonists using high-throughput synthesis

Bioorganic & medicinal chemistry, 2005-03, Vol.13 (5), p.1829-1836

2005

Volltextzugriff (PDF)

Rapid Evolution of a Fragment-like Molecule to Pan-Metallo-Beta-Lactamase Inhibitors: Initial Leads toward Clinical Candidates

Journal of medicinal chemistry, 2022-12, Vol.65 (24), p.16234-16251

2022

Volltextzugriff (PDF)

Discovery of sulfone containing metallo-β-lactamase inhibitors with reduced bacterial cell efflux and histamine release issues

Bioorganic & medicinal chemistry letters, 2024-12, Vol.114, p.129989, Article 129989

2024

Volltextzugriff (PDF)

Structure Guided Discovery of Novel Pan Metallo-β-Lactamase Inhibitors with Improved Gram-Negative Bacterial Cell Penetration

Journal of medicinal chemistry, 2024-03, Vol.67 (5), p.3400-3418

2024

Volltextzugriff (PDF)

Synthesis of novel bicyclo[4.1.0]heptane and bicyclo[3.1.0]hexane derivatives as melanin-concentrating hormone receptor R1 antagonists

Bioorganic & medicinal chemistry letters, 2007-09, Vol.17 (17), p.4845-4850

2007

Volltextzugriff (PDF)

1723. MK-3866, a metallo-β-lactamase inhibitor, is not subject to efflux in Pseudomonas aeruginosa

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Volltextzugriff (PDF)

MK-8325: A silyl proline-containing NS5A inhibitor with pan-genotype activity for treatment of HCV

Bioorganic & medicinal chemistry letters, 2018-06, Vol.28 (10), p.1954-1957

2018

Volltextzugriff (PDF)

Optimization of brain-penetrant picolinamide derived leucine-rich repeat kinase 2 (LRRK2) inhibitors

RSC medicinal chemistry, 2021-07, Vol.12 (7), p.1164-1173

2021

Volltextzugriff (PDF)

Discovery of silyl proline containing HCV NS5A inhibitors with pan-genotype activity: SAR development

Bioorganic & medicinal chemistry letters, 2016-03, Vol.26 (5), p.1475-1479

2016

Volltextzugriff (PDF)

Cesium Carbonate-Promoted Michael-Type Addition of Thiols to Hex-1-en-3-ulose: A Practical Synthesis of 2-Deoxy-1-thio-α-hexopyranosid-3-ulose Template

Synthetic communications, 2007-12, Vol.37 (23), p.4219-4226

2007

Volltextzugriff (PDF)

Quality by design (QbD) of amide isosteres: 5,5-Disubstituted isoxazolines as potent CRTh2 antagonists with favorable pharmacokinetic and drug-like properties

Bioorganic & medicinal chemistry letters, 2014-03, Vol.24 (6), p.1615-1620

2014

Volltextzugriff (PDF)

Quality by design (QbD) of amide isosteres: 5,5-Disubstituted isoxazolines as potent CRTh sub(2) antagonists with favorable pharmacokinetic and drug-like properties

Bioorganic & medicinal chemistry letters, 2014-03, Vol.24 (6), p.1615-1620

2014

Volltextzugriff (PDF)

Design and synthesis of tricyclic sulfones as γ-secretase inhibitors with greatly reduced Notch toxicity

Bioorganic & medicinal chemistry letters, 2010-04, Vol.20 (8), p.2591-2596

2010

Volltextzugriff (PDF)

Discovery of new SCH 39166 analogs as potent and selective dopamine D 1 receptor antagonists

Bioorganic & medicinal chemistry letters, 2010-02, Vol.20 (3), p.836-840

2010

Volltextzugriff (PDF)

Discovery of new SCH 39166 analogs as potent and selective dopamine D1 receptor antagonists

Bioorganic & medicinal chemistry letters, 2010-02, Vol.20 (3), p.836-840

2010

Volltextzugriff (PDF)

Discovery of new SCH 39166 analogs as potent and selective dopamine D sub(1) receptor antagonists

Bioorganic & medicinal chemistry letters, 2010-02, Vol.20 (3), p.836-840

2010

Volltextzugriff (PDF)

Design and synthesis of tricyclic sulfones as g-secretase inhibitors with greatly reduced Notch toxicity

Bioorganic & medicinal chemistry letters, 2010-04, Vol.20 (8), p.2591-2596

2010

Volltextzugriff (PDF)

Design and synthesis of tricyclic sulfones as y-secretase inhibitors with greatly reduced Notch toxicity

Bioorganic & medicinal chemistry letters, 2010, Vol.20 (8), p.2591-2596

2010

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(76)
Tagungsberichte
(1)

Sprache

Englisch
(76)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Stereoselective synthesis of C-6 hydroxy tricyclic sulfone as a γ-secretase inhibitor

Synthesis and SAR study of tricyclic sulfones as γ-secretase inhibitors: C-6 and C-8 positions

SAR studies of C2 ethers of 2H-pyrano[2,3-d]pyrimidine-2,4,7(1H,3H)-triones as nicotinic acid receptor (NAR) agonist

Chemoselective Peptide Modification via Photocatalytic Tryptophan β‑Position Conjugation

Modification of the clozapine structure by parallel synthesis

Discovery of SCH 900271, a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia

SAR of tricyclic sulfones as γ-secretase inhibitors

Discovery of melanin-concentrating hormone receptor R1 antagonists using high-throughput synthesis

Rapid Evolution of a Fragment-like Molecule to Pan-Metallo-Beta-Lactamase Inhibitors: Initial Leads toward Clinical Candidates

Discovery of sulfone containing metallo-β-lactamase inhibitors with reduced bacterial cell efflux and histamine release issues

Structure Guided Discovery of Novel Pan Metallo-β-Lactamase Inhibitors with Improved Gram-Negative Bacterial Cell Penetration

Synthesis of novel bicyclo[4.1.0]heptane and bicyclo[3.1.0]hexane derivatives as melanin-concentrating hormone receptor R1 antagonists

1723. MK-3866, a metallo-β-lactamase inhibitor, is not subject to efflux in Pseudomonas aeruginosa

MK-8325: A silyl proline-containing NS5A inhibitor with pan-genotype activity for treatment of HCV

Optimization of brain-penetrant picolinamide derived leucine-rich repeat kinase 2 (LRRK2) inhibitors

Discovery of silyl proline containing HCV NS5A inhibitors with pan-genotype activity: SAR development

Cesium Carbonate-Promoted Michael-Type Addition of Thiols to Hex-1-en-3-ulose: A Practical Synthesis of 2-Deoxy-1-thio-α-hexopyranosid-3-ulose Template

Quality by design (QbD) of amide isosteres: 5,5-Disubstituted isoxazolines as potent CRTh2 antagonists with favorable pharmacokinetic and drug-like properties

Quality by design (QbD) of amide isosteres: 5,5-Disubstituted isoxazolines as potent CRTh sub(2) antagonists with favorable pharmacokinetic and drug-like properties

Design and synthesis of tricyclic sulfones as γ-secretase inhibitors with greatly reduced Notch toxicity

Discovery of new SCH 39166 analogs as potent and selective dopamine D 1 receptor antagonists

Discovery of new SCH 39166 analogs as potent and selective dopamine D1 receptor antagonists

Discovery of new SCH 39166 analogs as potent and selective dopamine D sub(1) receptor antagonists

Design and synthesis of tricyclic sulfones as g-secretase inhibitors with greatly reduced Notch toxicity

Design and synthesis of tricyclic sulfones as y-secretase inhibitors with greatly reduced Notch toxicity

Suchergebnisse filtern